TrialAlzheimer's research & therapy2021

A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia.

Shifu Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.